Intelligent Bio Solutions
INBS
5 hedge funds and large institutions have $291K invested in Intelligent Bio Solutions in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
150% more funds holding
Funds holding: 2 → 5 (+3)
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
0% more ownership
Funds ownership: 0% → 0% (+0%)
20% less capital invested
Capital invested by funds: $365K → $291K (-$74K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$207K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$138K |
| 3 |
BlackRock
New York
|
+$17.2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$17.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$17.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$230K |
| 2 |
Jane Street
New York
|
-$120K |
| 3 |
FIA
FNY Investment Advisers
New York
|
-$7K |
INBS Hedge Fund Activity: Q1 2021 in Review
5 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q1 2021, worth a combined $291K — down 20% from $365K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new INBS positions and 2 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $207K. The largest seller was Anson Funds Management, exiting entirely with an estimated $230K sold.
- 5 institutional investors held Intelligent Bio Solutions (INBS) as of Q1 2021, up from 2 in Q4 2020.
- Funds reported $291K of Intelligent Bio Solutions stock for Q1 2021, down 20% quarter-over-quarter.
- 5 funds opened new Intelligent Bio Solutions positions in Q1 2021 and 2 closed out, a net change of +3 holders.
- The largest Intelligent Bio Solutions buyer in Q1 2021 was Citadel Advisors, an estimated $207K added.
- The largest Intelligent Bio Solutions seller in Q1 2021 was Anson Funds Management, an estimated $230K sold.
Based on aggregated 13F filings for Q1 2021.